In a mouse xenograft model for human NSCLC, IL-33 mediated the amplification of the M2 markers on macrophages in vitro and in vivo, thereby facilitating the suppressive activity of TAMs. The gene discussed is IL33; the disease is non-small cell lung carcinoma.